| Terms |
Definitions |
|
Memantine
|
NMDA receptor antagonist may have neuroprotective properties may slow progression of Alzheimer's
|
|
Why combine L-dopa with Selegiline?
|
This is a MAO B inhibitor. It decreases dopamine breakdown in the brain, but does not cause catecolamine build-up in the peripheral tissues (no HTN crisis).
|
|
Why give l-dopa gradually? What does L-dopa do?
|
Reduce side effects and toxicityReduces bradykinesia and rigidity, less effective in reducing tremor.
|
|
Which tissues in the brain are affected because of PK's?
|
Striatal tissue (caudate and putamen) show 10% of normal dopamine
|
|
What are the low dose atypical antipsychotics? Why use them?
|
Risperidone, Olanzapine, QuetiapineControl hallucinations caused by l-dopa
|
|
Most obvious early sign of Parkinson's?
|
Tremor- usually pill-rolling
|
|
Long term complications of L-dopa
|
abnormal involuntary movements, faciolingual tics, bobbing,and rocking movements. *decreased affectiveness of l-dopa leading to on-off phenomenon
|
|
COMT inhibitors
|
TolcaponeEntacopone
|
|
Somewhat selective D2,D3 DA receptor agonists
|
Ropinirole/Pramipexole
|
|
L-dopa, carbidopa, Sinemet, bromocriptine, ropinirole, pramipexole, amantadine, selegiline, propranolol, benztropine, trihexyphenidyl, entacapone
|
Parkinson's
|
|
Dopamine agonists
|
Bromocriptine/Pergolide
|
|
Where is dopamine made? What does this area display in PK's?
|
Pars compacta of the substantia nigraDegeneration of the dopaminergic neurons
|
|
Recommendations for early stage Parkinson's
|
Dopamine agonists (pramipexole or ropinirole)
|
|
What is the on-off phenomenon?
|
Partial l-dopa resistance due to pronlonged treatment leads to asymptomatic followed by severe symptom cycles.
|
|
Why do you combine Carbidopa with L-dopa?
|
Carbidopa is a peripheral L-aromatic Decarboxylase inhibitor. Coadministration allows lower doses of L-dopa to be given and still get to the brain.
|
|
What is the normal pathway of dopamine?
|
Pars Compacta of Substantia Nigra -- release of DA -- D2 (inhibits cholinergic release Ach)and D2 (inhibits muscarinic release GABA to Globus Pallidus)
|
|
Dopamine precursorsReplenishes dompamine in striatum
|
l-dopa
|
|
What is the offending neurotransmitter in PK's?
|
Dopamine
|
|
Why combine bromocriptine with l-dopa?
|
Reduce on-off phenomenon
|
|
What's the affect of decreased dopamine on the pathway? How should we treat the defect?
|
Decreased D2 inhibition, increased release of Ach. Replace dopamine and block Ach
|
|
Contraindication of L-dopa
|
Never with MAOI- would result in massive increase of sympathomimetic amines leading to hypertensive crisis. Antipsychotic drugs (pnenothiazine or butyrophenone) antagonize l-dopa.
|
|
Selegiline (Deprenyl)(se le' ji leen)
|
MAO B inhibitor, predomintates in the brain
|
|
Pathology of Alzheimer's
|
Brain accumulation of plaques and tangles composed of Beta amyloid
|
|
MA of Selegiline, side effects
|
Prevents oxidation of dopamine in brainMay cause HTN at high dose
|
|
Can we give exogenous dopamine for treatment of PK's?
|
No, doesn't cross BBB, give L-dopa which does.
|
|
Other drugs being considered for Alzheimer's
|
NSAIDS, estrogen, nicotine, statins
|
|
RopinirolPramipexole
|
Dopamine agonists
|
|
Side effects of l-dopa
|
nausea, orthostatic hypotension, arrhythmias, hallucinations, delusions, dyskinesias
|
|
Muscarinic cholinergic receptor antagonists
|
BenztropineTrihexyphenidyl
|
|
Why are side effects such as emesis and hypotension a problem w/dopamine agonists?
|
They activate peripheral dopamine receptors
|
|
Effect of DA agonists
|
Stimulate DP receptors in striatum. Reduce on-off
|
|
Why use CAAs? Side effects?
|
Reduce tremordry mouth, blurred vision, urinary retension
|
|
Indirectly causes the release of endogenous DASide effects?
|
AmantidineHallucinations
|
|
Amantidine
|
Antiviral drug found to improve Parkinson symptoms. Releases endogenous DA
|
|
peripheral l-aromatic decarboxylase inhibitor (does not enter brain)
|
Carbidopa
|
|
How many does Parkinson's affect?
|
1% over 50
|
|
Side effects of Carbidopa
|
|
|
How much degeneration do you need in PK's to show disfunction?
|
≧70%
|
|
Bromocriptine, Pergolide
|
Dopamine agonists
|
|
Why use selegiline in newly diagnosed patient?
|
May delay the onset of symptoms
|
|
How can we avoid agonist side effects?
|
Achieve a higher T.I. by combining with a dopaminergic antagonist
|
|
Most common form of dementia
|
Alzheimer's- progressive impairment of memory and cognitive fxn.
|
|
MAO B inhibitor
|
Selegiline
|
|
How long w/o treatment before death? With?
|
9 years20 years
|
|
MA for MS cholinergic receptor antagonists
|
Block muscarinic receptors in striatum- useful only very early in dz
|
|
Recommendations when DA agonists no longer work
|
Add l-dopa and carbidopaCan add COMT inhibitors (entacapone) to reduce wearing off periods
|
|
Tacrine, donepezil, rivastigmine, galantamime, memantine
|
Alzheimer's
|
|
What are the side effects of L-dopa?
|
Nausea- stimulation of DA receptors in area postrema of medulla. Orthostatic hypotension- presynaptic DAr inhibit NE release that would normally constrict vessels.Cardiac arrhythmias- DA stim of Beta receptorsPsychotic-like symptoms- Activate DAr in mesolimbic system.
|
|
Symptoms of Parkinson's
|
akinesiatremorrigidityalteration of posture, mask-like face, shuffling gait, loss of associative movment, and hypersalivation
|
|
Side effects of MSCR antagonists
|
Dry mouth, blurry vision, urinary retention
|
|
Is the on-off phenomenon avoided by combination with carbidopa?
|
No, may even be worse.
|
|
Difference between Tacrine and donepezil, rivastigmine, and galantamine?
|
Tacrine is non-selective, the others are brain-selective
|
|
MA of Carbidopa
|
prevents conversion of l-dopa to dopamine in peripheral tissues
|
|
How much L-dopa do we give? Why?
|
Large doses, more than 95% ingested is decarboxylated in peripheral tissues.
|
|
Side effects of agonists
|
Nausea, hypotension, dyskinesia, hallucinations, and delusions
|
|
MA of COMT inhibitors
|
prevent breakdown of l-dopa by COMT
|
|
Four drugs used to treat Alzheimer's. All are...?
|
TacrineDonepezilRivastigimineGalantamineAll ACEi
|
|
When given with carbidopa, how much l-dopa should be give to reach the TE?
|
75% less than w/o carbidopa
|
|
Centrally acting anticholinergics (CAA)
|
BenztropineTrihexyphenidyl
|
|
Side effects of DA agonists
|
Nausea, Ortho hypotension, hallucinations, delusions, dyskinesias
|
|
How is the rigidity in PK's characterized?
|
cogwheel
|
|
What does selegiline do? What are it's advantages?
|
decrease breakdown of dopamine in brain, but don't cause catecholamine build up in peripheral tissues, therefore no HTN crisis
|
|
Sinemet
|
1 part carbidopa to 10 parts l-dopa, most widely used med for Parkinson's
|
|
Adverse effects of Alzheimer drugs
|
Nausea, vomiting, diarrhea, abdominal pain, anorexia*Tacrine has hepatic toxicity
|